Home-Based Exercise for Heart Failure
(MOVE-LVAD II Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how a home-based exercise program using mobile technology can benefit individuals with a new HeartMate 3 left ventricular assist device (LVAD). The researchers aim to determine if this exercise program can improve physical activity, muscle strength, and quality of life compared to usual care. Participants will either follow a guided exercise plan using a smartphone app or maintain their normal daily routine. This trial suits individuals living at home with a newly implanted HeartMate 3 LVAD who can walk independently and have a smartphone with internet access. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance daily life for LVAD patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this home-based exercise program using mobile technology is safe for patients with a HeartMate 3 left ventricular assist device?
Research has shown that exercising at home with mobile technology is generally safe for people with heart conditions. A review of studies found that patients with heart disease respond well to these programs. Participants typically exercise at home using digital tools like fitness watches and smartphone apps, which assist them in following their exercise plans.
Another study found that mobile health (mHealth) technology can safely help people develop exercise habits. This technology enables patients to exercise independently and share their progress with healthcare providers. This approach not only tracks exercise but also ensures it is done safely.
In summary, using mobile technology to guide home exercise appears to be a safe and effective option for people with heart conditions, including those with heart devices.12345Why are researchers excited about this trial?
Researchers are excited about the home-based exercise program for heart failure because it utilizes mobile technology to provide a personalized and flexible approach to exercise. Unlike traditional cardiac rehab programs that require in-person attendance, this program leverages activity-tracking watches and smartphone apps to guide and progress exercise routines at home. This method not only enhances accessibility for patients who may struggle with transportation or time constraints but also encourages consistent physical activity, which is crucial for improving heart health. By integrating technology, this exercise program offers a modern, convenient, and potentially more sustainable way to manage heart failure symptoms.
What evidence suggests that this home-based exercise program using mobile technology is effective for heart failure patients with a newly implanted HeartMate 3 LVAD?
Research shows that home-based exercise programs using mobile technology can effectively boost physical activity and fitness in heart patients. In this trial, participants in the Exercise Intervention arm will follow such a program, which studies have shown to improve fitness levels as effectively as traditional supervised programs. Specifically, past participants demonstrated better walking ability, an important measure of fitness. Additionally, mobile technology aids in maintaining exercise routines by providing guidance and tracking progress. Overall, home-based exercise programs offer a promising way to improve health in patients with heart conditions.23678
Who Is on the Research Team?
Himabindu Vidula, MD
Principal Investigator
University of Pennsylvania
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've just had a HeartMate 3 LVAD implanted and can walk on their own (even with help from a device). They must have a smartphone with internet because the exercise program uses mobile tech. It's for those going home or living at home with the LVAD within 45 days after leaving the hospital.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline assessments including daily step measurement, six-minute walk test, frailty testing, and CT scan for muscle mass evaluation
Treatment
Participants are randomized to either the exercise intervention or usual care. The exercise group receives personalized exercise prescriptions and remote monitoring, while the usual care group is encouraged to increase walking
Follow-up
Participants are monitored for safety and effectiveness after treatment, including questionnaires, six-minute walk testing, frailty testing, and CT scans
What Are the Treatments Tested in This Trial?
Interventions
- Home-Based Exercise Program Using Mobile Technology
Home-Based Exercise Program Using Mobile Technology is already approved in United States for the following indications:
- Improvement of physical activity and capacity in patients with HeartMate 3 LVAD
- Reduction of frailty and muscle mass loss in patients with HeartMate 3 LVAD
- Enhancement of quality of life in patients with HeartMate 3 LVAD
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator